{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:29:54Z","timestamp":1793975394079,"version":"4.8.0"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>We report on three children with novel variants in the lipolysis-stimulated lipoprotein receptor (<jats:italic>LSR<\/jats:italic>) gene with clinical presentation with early onset intrahepatic cholestasis and the main symptom being uncontrollable itching. Two patients showed dystrophy, short stature and microcephaly, whilst one patient had neurological developmental delay. LSR is one component of special tricellular tight junctions (tTJs) with expression in the liver and brain. We analyzed clinical data for all patients and performed multigene panel sequencing followed by Human Phenotype Ontology (HPO) based exome analysis, classifying the sequenced variants according to the American College of Medical Genetics and Genomics (ACMG) guidelines. We performed immunostaining on the liver cryosections. The lack of LSR expression in immunofluorescence of the patients\u2019 liver tissue confirmed the pathogenicity of genetic variants. We analyzed bile acids (BA) and their derivatives by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) in two of the three patients, confirming disturbed bile salt secretion. We also describe the use of an ileal bile acid transport (IBAT) inhibitor in two patients with LSR-associated intrahepatic cholestasis for the first time. Both patients showed a good response to the therapy in terms of itch control. In conclusion, LSR-associated early onset intrahepatic cholestasis is a new and likely underdiagnosed disease. Patients with an unclear progressive familial intrahepatic cholestasis (PFIC)-like clinical picture should therefore undergo genetic testing of the <jats:italic>LSR<\/jats:italic> gene. Treatment with an IBAT inhibitor should be considered.<\/jats:p>","DOI":"10.3389\/fped.2025.1582769","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:05Z","timestamp":1756963985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of LSR gene variants in early onset intrahepatic cholestasis: a case series with treatment options"],"prefix":"10.3389","volume":"13","author":[{"given":"Sinja","family":"Ohlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Zaufel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Qvartskhava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Hinreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo A.","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benas","family":"Prusinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kubitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"G\u00f6rg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diran","family":"Herebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Lainka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Kathemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/humu.23770","article-title":"Novel missense mutation in VPS33B is associated with isolated low gamma-glutamyltransferase cholestasis: attenuated, incomplete phenotype of arthrogryposis, renal dysfunction, and cholestasis syndrome","volume":"40","author":"Qiu","year":"2019","journal-title":"Hum Mutat"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.3748\/wjg.v26.i47.7470","article-title":"Molecular overview of progressive familial intrahepatic cholestasis","volume":"26","author":"Amirneni","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/hep.31087","article-title":"Organic solute transporter alpha deficiency: a disorder with cholestasis, liver fibrosis, and congenital diarrhea","volume":"71","author":"Gao","year":"2020","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","article-title":"Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants","volume":"21","author":"Maddirevula","year":"2019","journal-title":"Genet Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/jmedgenet-2019-106706","article-title":"Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis","volume":"58","author":"Luan","year":"2021","journal-title":"J Med Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e14563","DOI":"10.15252\/emmm.202114563","article-title":"A homozygous R148W mutation in semaphorin 7A causes progressive familial intrahepatic cholestasis","volume":"13","author":"Pan","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jpeds.2020.01.064","article-title":"Biallelic mutations in the LSR gene cause a novel type of infantile intrahepatic cholestasis","volume":"221","author":"Uehara","year":"2020","journal-title":"J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1242\/jcs.072058","article-title":"LSR defines cell corners for tricellular tight junction formation in epithelial cells","volume":"124","author":"Masuda","year":"2011","journal-title":"J Cell Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/j.1432-1033.2004.04223.x","article-title":"Distribution of the lipolysis stimulated receptor in adult and embryonic murine tissues and lethality of LSR-\/- embryos at 12.5 to 14.5 days of gestation","volume":"271","author":"Mesli","year":"2004","journal-title":"Eur J Biochem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ng.2918","article-title":"Mutations in TJP2 cause progressive cholestatic liver disease","volume":"46","author":"Sambrotta","year":"2014","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1582769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:33:06Z","timestamp":1756963986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1582769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":12,"alternative-id":["10.3389\/fped.2025.1582769"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1582769","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1582769"}}